期刊文献+

辛伐他汀纳米脂质载体的制备及大鼠体内药动学 被引量:1

Preparation and Pharmacokinetics of Simvastatin Nanostructured Lipid Carriers in Rats
原文传递
导出
摘要 采用乳化溶剂蒸发法制备辛伐他汀(1)纳米脂质载体(1-NLC),考察了其理化特性、在体肠吸收特性和大鼠体内药动学。结果表明,1-NLC平均粒径为(72.1±47.2)nm,包封率为(94.6±2.5)%,载药量为(5.78±0.57)%。在体肠吸收研究表明,与原药相比,1-NLC在十二指肠、空肠和回肠的吸收速率常数分别提高了0.5、1.3和0.6倍。大鼠体内药动学研究表明,与1混悬液组相比,1-NLC组的1及其活性代谢物辛伐他汀酸的口服生物利用度分别为222%和269%。 Simvastatin loaded nanostructured lipid carriers (1-NLC) were prepared by emulsification solvent evaporation technique. The physicochemical properties, in situ intestinal absorption and pharmacokinetic behavior in rats of 1-NLC were investigated. The results showed that 1-NLC was nanometer-sized particle with the mean diameter of (72.1±47.2)nm and the entrapment efficiency of 1-NLC was (94.6±2.5) % with the drug loading of (5.78±0.57) %. Compared with bulk drug suspension group, the absorption rate constant in duodenum, jejunum and ileum of 1-NLC group were increased by 50%, 130% and 60%, respectively. The results of pharmacokinetics in rats showed the oral bioavailability of simvastatin and its active metabolite, simvastatin acid, in 1-NLC group were 222 % and 269 % compared with the suspension group.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2013年第1期46-49,共4页 Chinese Journal of Pharmaceuticals
基金 国家重大科学研究计划项目(2009CB930304)
关键词 辛伐他汀 辛伐他汀酸 纳米脂质载体 制备 吸收 药动学 simvastatin simvastatin acid nanostructured lipid carrier preparation absorption pharmacokinetics
  • 相关文献

参考文献7

二级参考文献23

  • 1姚继红,苏成业,储晓岩.长春西汀在大鼠体内的药代动力学及生理处置[J].药学学报,1994,29(2):81-85. 被引量:6
  • 2Stewart BH, Chan OH, Lu RH, et al. Comparison of intestinal permeabilities determined in multiple in vitro and in situ models:relationship to absorption in humans [J]. Pharm Res, 1995,12 (5) : 693-699. 被引量:1
  • 3Fagerholm U, Johansson M, Lennernas H. Comparsion between permeability coefficients in rat and human jejunum[J]. Pharm Res, 1996, 13(9): 1336-1342. 被引量:1
  • 4Le Corre P, Dollo G, Chevanne F, et al. Influence of hydroxypropyl-β-cyclodextrin and dimethyl-β-cyclodextrin on diphenhydramine intestinal absorption in a rat in situ model[J]. Int J Pharm, 1998, 169 (2) : 221-228. 被引量:1
  • 5Lohmann A, Dingier E, Sommer W, et al. Bioavailability of vinpocetine and interference of the time of application with food intake [J]. Arzneim-Forsch, 1992, 42 (7): 914-917. 被引量:1
  • 6Stella VJ, Rao VM, Zannou EA, et al, Mechanisms of drug release from cyclodextrin complexes [J]. Adv Drug Deliv Rev,1999, 36(1): 3-16. 被引量:1
  • 7Duchene D, Wouessidjewe D, Ponchel G. Cyclodextrins and carrier systems [J]. J Controlled Release, 1999, 62 (1-2) :263-268. 被引量:1
  • 8Hirayarna F, Uekama K. Cyclodextrin-based controlled drug release system[J]. Adv Drug Deliv Rev, 1999, 36(1) : 125-141. 被引量:1
  • 9Kang BK, Lee JS, Chon SK, et al. Development of selfmicroemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs [J]. Int J Pharm, 2004, 274 (1-2) : 65-73. 被引量:1
  • 10梁文权.生物药剂学与药物动力学[M].1版,北京:人民卫生出版社.1998:241-252. 被引量:1

共引文献23

同被引文献13

  • 1Shapiro NI, Aird WC. Sepsis and the broken endothelium [ J ] Crit Care, 2011, 15 (2): 135. 被引量:1
  • 2Gill S, Brown AJ. Exploiting a physiological regulator to improve the efficacy and safety of statins [ J]. Cardio l)rugs & Therapy, 2011, 25 (2): 183-185. 被引量:1
  • 3yon Mahzahn G, Park JH, Lin KY, et al. Nanoparticles that communicate in vivo to amplify tumor targetiug [J . Nature Materials, 2011, 10 (7): 545-552. 被引量:1
  • 4Panyam J, Labhasetwar V. Biodegradable nanoparticles tor daag and gene delivery to cells and tissue [J]. Adv Drug Deliv Rev, 2003, 55 (3) : 329-347. 被引量:1
  • 5Lin A, Sabnis A, Kona S, et al. Shear-regulated uptake of nanopartieles by endothelial cells and development of endothelial- targeting nanopartieles [ J ]. J Biomed Mater Res A, 2010, 93 (3) : 833-842. 被引量:1
  • 6flU FQ, JIANG SP, DU YZ, et al. Preparation and characterization of stearie acid nanostruetured lipid carriers by solvent difl'usion method in an aqueous system [J]. Colloids Surf B, 2005, 45 (3/ 4) : 167-173. 被引量:1
  • 7Auinger S, Small JV. Correlated light and electron mieruscopy of the cytoskeleton [J]. Methods Cell Biol, 2008, 88 (2): 257-272. 被引量:1
  • 8Tleyjeh IM, Kashour T, Hakim FA, et al. Statins tbr the prevention and treatment of' infections: a systematic review and meta-analysis[J]. Arch Intern Med , 2009, 169 (18) : 1658-1667. 被引量:1
  • 9Fortin CF, McDonald PP, Ftilp T, el al. Sepsis, leukocyies, and nitric oxide (NO): an intricate affair [ J]. Shock, 2010, 33 (4) : 344-352. 被引量:1
  • 10McGown CC, Brown NJ, Hellewell PG, et al. Beneficial microvascu|ar and anti-inflammatory effects of pravastalin duringsepsis involve nitric oxide synthase III[ J]. Br Anaesth, 2010, 104 (2) : 183-190. 被引量:1

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部